Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.28 Bil Enterprise Value: 9.84 Bil PE Ratio: 30.13 PB Ratio: 2.80 GF Score: 88/100

Qiagen NV at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 03:20PM GMT
Release Date Price: €42.71 (+1.23%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right. Good morning, and good afternoon, everybody. It's our pleasure to welcome Thierry Bernard from QIAGEN to the Cowen Conference. On the line, we also have from Investor Relations, Phoebe Loh and John Galardi. Thanks to all of you for being here. So Thierry brings extensive experience in molecular diagnostics, commercial operations, and international business to QIAGEN, prior to QIAGEN, as many of you know, he worked for bioMérieux for 15 years and led various business functions and units there.

So thank you for being here today. Always a pleasure to catch up with you about all things, diagnostics and all things, QIAGEN. We have an ambitious agenda to get through over the next half hour. I think, Thierry, just correct me if I'm wrong, did you want to make some opening remarks before we got into it? Or do you want me to just start throwing some questions at you?

Thierry Bernard
QIAGEN N.V. - CEO, MD & Member of Management Board

I think we can go

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot